135 related articles for article (PubMed ID: 26942413)
1. Effect of Antiglaucoma Medicine on Intraocular Pressure in DBA/2J Mice.
Sawada K; Hiraoka M; Ohguro H
Ophthalmic Res; 2016; 55(4):205-11. PubMed ID: 26942413
[TBL] [Abstract][Full Text] [Related]
2. Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.
Matsubara A; Nakazawa T; Husain D; Iliaki E; Connolly E; Michaud NA; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2498-507. PubMed ID: 16723462
[TBL] [Abstract][Full Text] [Related]
3. Calibration of the TonoLab tonometer in mice with spontaneous or experimental glaucoma.
Pease ME; Cone FE; Gelman S; Son JL; Quigley HA
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):858-64. PubMed ID: 20720229
[TBL] [Abstract][Full Text] [Related]
4. Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice.
Scholz M; Buder T; Seeber S; Adamek E; Becker CM; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):613-21. PubMed ID: 18235006
[TBL] [Abstract][Full Text] [Related]
5. The activity of lowering intraocular pressure of cassiae seed extract in a DBA/2J mouse glaucoma model.
Horng CT; Tsai ML; Chien ST; Kao WT; Tsai MK; Chang TH; Chen FA
J Ocul Pharmacol Ther; 2013 Feb; 29(1):48-54. PubMed ID: 23039184
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer.
Wang WH; Millar JC; Pang IH; Wax MB; Clark AF
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4617-21. PubMed ID: 16303957
[TBL] [Abstract][Full Text] [Related]
7. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
[TBL] [Abstract][Full Text] [Related]
8. Assessment of inner retina dysfunction and progressive ganglion cell loss in a mouse model of glaucoma.
Pérez de Lara MJ; Santano C; Guzmán-Aránguez A; Valiente-Soriano FJ; Avilés-Trigueros M; Vidal-Sanz M; de la Villa P; Pintor J
Exp Eye Res; 2014 May; 122():40-9. PubMed ID: 24631335
[TBL] [Abstract][Full Text] [Related]
9. Time course of age-dependent changes in intraocular pressure and retinal ganglion cell death in DBA/2J mouse.
Zhang X; Zhang M; Avila MY; Ge J; Laties AM
Yan Ke Xue Bao; 2006 Sep; 22(3):184-9, 194. PubMed ID: 17162904
[TBL] [Abstract][Full Text] [Related]
10. IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice.
Nagaraju M; Saleh M; Porciatti V
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4573-9. PubMed ID: 17898280
[TBL] [Abstract][Full Text] [Related]
11. Ocular hypotensive effects of anti-glaucoma agents in mice.
Akaishi T; Odani-Kawabata N; Ishida N; Nakamura M
J Ocul Pharmacol Ther; 2009 Oct; 25(5):401-8. PubMed ID: 19857101
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma.
Steele MR; Inman DM; Calkins DJ; Horner PJ; Vetter ML
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):977-85. PubMed ID: 16505032
[TBL] [Abstract][Full Text] [Related]
13. Quantification of deficits in spatial visual function of mouse models for glaucoma.
Burroughs SL; Kaja S; Koulen P
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3654-9. PubMed ID: 21330670
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma.
Saleh M; Nagaraju M; Porciatti V
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4564-72. PubMed ID: 17898279
[TBL] [Abstract][Full Text] [Related]
15. Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model.
Schuettauf F; Quinto K; Naskar R; Zurakowski D
Vision Res; 2002 Sep; 42(20):2333-7. PubMed ID: 12350421
[TBL] [Abstract][Full Text] [Related]
16. Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: a 3-month, open-label, replacement study in glaucoma patients.
Nguyen QH; Earl M
J Ocul Pharmacol Ther; 2009 Dec; 25(6):541-4. PubMed ID: 20028261
[TBL] [Abstract][Full Text] [Related]
17. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
19. Ocular Treatments Targeting Separate Prostaglandin Receptors in Mice Exhibit Alterations in Intraocular Pressure and Optic Nerve Lipidome.
Arcuri J; Elbaz A; Sharif NA; Bhattacharya SK
J Ocul Pharmacol Ther; 2023 Oct; 39(8):541-550. PubMed ID: 37267222
[No Abstract] [Full Text] [Related]
20. The efficacy of TonoLab in detecting physiological and pharmacological changes of mouse intraocular pressure--comparison with TonoPen and microneedle manometery.
Saeki T; Aihara M; Ohashi M; Araie M
Curr Eye Res; 2008 Mar; 33(3):247-52. PubMed ID: 18350435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
